98 related articles for article (PubMed ID: 16245186)
1. Construction of a novel extracellular matrix using a new genetically engineered epidermal growth factor fused to IgG-Fc.
Ogiwara K; Nagaoka M; Cho CS; Akaike T
Biotechnol Lett; 2005 Oct; 27(20):1633-7. PubMed ID: 16245186
[TBL] [Abstract][Full Text] [Related]
2. An artificial extracellular matrix created by hepatocyte growth factor fused to IgG-Fc.
Azuma K; Nagaoka M; Cho CS; Akaike T
Biomaterials; 2010 Feb; 31(5):802-9. PubMed ID: 19846215
[TBL] [Abstract][Full Text] [Related]
3. Effect of photo-immobilization of epidermal growth factor on the cellular behaviors.
Ogiwara K; Nagaoka M; Cho CS; Akaike T
Biochem Biophys Res Commun; 2006 Jun; 345(1):255-9. PubMed ID: 16678132
[TBL] [Abstract][Full Text] [Related]
4. Detection and localization of Cripto-1 binding in mouse mammary epithelial cells and in the mouse mammary gland using an immunoglobulin-cripto-1 fusion protein.
Bianco C; Normanno N; De Luca A; Maiello MR; Wechselberger C; Sun Y; Khan N; Adkins H; Sanicola M; Vonderhaar B; Cohen B; Seno M; Salomon D
J Cell Physiol; 2002 Jan; 190(1):74-82. PubMed ID: 11807813
[TBL] [Abstract][Full Text] [Related]
5. Cytolytic and cytostatic properties of an anti-human Fc gammaRI (CD64) x epidermal growth factor bispecific fusion protein.
Goldstein J; Graziano RF; Sundarapandiyan K; Somasundaram C; Deo YM
J Immunol; 1997 Jan; 158(2):872-9. PubMed ID: 8993006
[TBL] [Abstract][Full Text] [Related]
6. A truncated soluble epidermal growth factor receptor-Fc fusion ligand trap displays anti-tumour activity in vivo.
Adams TE; Koziolek EJ; Hoyne PH; Bentley JD; Lu L; Lovrecz G; Ward CW; Lee FT; Scott AM; Nash AD; Rothacker J; Nice EC; Burgess AW; Johns TG
Growth Factors; 2009 Jun; 27(3):141-54. PubMed ID: 19333814
[TBL] [Abstract][Full Text] [Related]
7. The bioactivity and receptor affinity of recombinant tagged EGF designed for tissue engineering applications is defined by the nature and position of the tags.
Boucher C; St-Laurent G; Loignon M; Jolicoeur M; De Crescenzo G; Durocher Y
Tissue Eng Part A; 2008 Dec; 14(12):2069-77. PubMed ID: 18652537
[TBL] [Abstract][Full Text] [Related]
8. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
Ding W; Shi W; Bellusci S; Groffen J; Heisterkamp N; Minoo P; Warburton D
J Cell Physiol; 2007 Sep; 212(3):796-806. PubMed ID: 17516543
[TBL] [Abstract][Full Text] [Related]
9. Prolactin modulates phosphorylation, signaling and trafficking of epidermal growth factor receptor in human T47D breast cancer cells.
Huang Y; Li X; Jiang J; Frank SJ
Oncogene; 2006 Dec; 25(58):7565-76. PubMed ID: 16785991
[TBL] [Abstract][Full Text] [Related]
10. Rational design of an EGF-IL18 fusion protein: implication for developing tumor therapeutics.
Lu JX; Peng Y; Meng ZF; Jin LQ; Lu YS; Guan MX
Biochem Biophys Res Commun; 2005 Aug; 334(1):157-61. PubMed ID: 15993840
[TBL] [Abstract][Full Text] [Related]
11. Collagen-binding human epidermal growth factor promotes cellularization of collagen scaffolds.
Yang Y; Zhao Y; Chen B; Han Q; Sun W; Xiao Z; Dai J
Tissue Eng Part A; 2009 Nov; 15(11):3589-96. PubMed ID: 19480569
[TBL] [Abstract][Full Text] [Related]
12. Thalidomide inhibits epidermal growth factor-induced cell growth in mouse and human monocytic leukemia cells via Ras inactivation.
Noman AS; Koide N; Khuda II; Dagvadorj J; Tumurkhuu G; Naiki Y; Komatsu T; Yoshida T; Yokochi T
Biochem Biophys Res Commun; 2008 Oct; 374(4):683-7. PubMed ID: 18662673
[TBL] [Abstract][Full Text] [Related]
13. Micropatterned immobilization of epidermal growth factor to regulate cell function.
Ito Y; Chen G; Imanishi Y
Bioconjug Chem; 1998; 9(2):277-82. PubMed ID: 9548545
[TBL] [Abstract][Full Text] [Related]
14. Expression of a functional epidermal growth factor receptor on human adipose-derived mesenchymal stem cells and its signaling mechanism.
Baer PC; Schubert R; Bereiter-Hahn J; Plösser M; Geiger H
Eur J Cell Biol; 2009 May; 88(5):273-83. PubMed ID: 19167776
[TBL] [Abstract][Full Text] [Related]
15. Unique role of SNT-2/FRS2beta/FRS3 docking/adaptor protein for negative regulation in EGF receptor tyrosine kinase signaling pathways.
Huang L; Watanabe M; Chikamori M; Kido Y; Yamamoto T; Shibuya M; Gotoh N; Tsuchida N
Oncogene; 2006 Oct; 25(49):6457-66. PubMed ID: 16702953
[TBL] [Abstract][Full Text] [Related]
16. Role of extracellular matrix-cell interaction and epidermal growth factor (EGF) on EGF-receptors and actin cytoskeleton arrangement in infantile pituitary cells.
Toral C; Solano-Agama C; Reyes-Márquez B; Sabanero M; Talamás P; González del Pliego M; Mendoza-Garrido ME
Cell Tissue Res; 2007 Jan; 327(1):143-53. PubMed ID: 16941125
[TBL] [Abstract][Full Text] [Related]
17. Growth factor-induced MAPK network topology shapes Erk response determining PC-12 cell fate.
Santos SD; Verveer PJ; Bastiaens PI
Nat Cell Biol; 2007 Mar; 9(3):324-30. PubMed ID: 17310240
[TBL] [Abstract][Full Text] [Related]
18. Epidermal growth factor stimulates Rac activation through Src and phosphatidylinositol 3-kinase to promote colonic epithelial cell migration.
Dise RS; Frey MR; Whitehead RH; Polk DB
Am J Physiol Gastrointest Liver Physiol; 2008 Jan; 294(1):G276-85. PubMed ID: 17991704
[TBL] [Abstract][Full Text] [Related]
19. EGF-R regulates MMP function in fibroblasts through MAPK and AP-1 pathways.
Kajanne R; Miettinen P; Mehlem A; Leivonen SK; Birrer M; Foschi M; Kähäri VM; Leppä S
J Cell Physiol; 2007 Aug; 212(2):489-97. PubMed ID: 17348021
[TBL] [Abstract][Full Text] [Related]
20. Application of the Fc fusion format to generate tag-free bi-specific diabodies.
Asano R; Ikoma K; Kawaguchi H; Ishiyama Y; Nakanishi T; Umetsu M; Hayashi H; Katayose Y; Unno M; Kudo T; Kumagai I
FEBS J; 2010 Jan; 277(2):477-87. PubMed ID: 20015073
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
